Stonegate Investment Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Sell |
4,072
-256
| -6% | -$28.4K | 0.01% | 252 |
|
|
2025
Q1 | $485K | Sell |
4,328
-1,819
| -30% | -$204K | 0.01% | 219 |
|
|
2024
Q4 | $568K | Sell |
6,147
-641
| -9% | -$59.2K | 0.02% | 201 |
|
|
2024
Q3 | $569K | Sell |
6,788
-244
| -3% | -$20.5K | 0.02% | 212 |
|
|
2024
Q2 | $482K | Buy |
7,032
+29
| +0.4% | +$1.99K | 0.01% | 225 |
|
|
2024
Q1 | $513K | Sell |
7,003
-294
| -4% | -$21.5K | 0.02% | 214 |
|
|
2023
Q4 | $591K | Buy |
7,297
+460
| +7% | +$37.3K | 0.02% | 191 |
|
|
2023
Q3 | $512K | Buy |
6,837
+2,923
| +75% | +$219K | 0.02% | 197 |
|
|
2023
Q2 | $302K | Sell |
3,914
-1,500
| -28% | -$116K | 0.01% | 248 |
|
|
2023
Q1 | $449K | Sell |
5,414
-75
| -1% | -$6.22K | 0.02% | 216 |
|
|
2022
Q4 | $471K | Sell |
5,489
-135
| -2% | -$11.6K | 0.02% | 208 |
|
|
2022
Q3 | $347K | Buy |
5,624
+726
| +15% | +$44.8K | 0.02% | 211 |
|
|
2022
Q2 | $303K | Buy |
+4,898
| New | +$303K | 0.01% | 229 |
|
|
2022
Q1 | – | Sell |
-3,132
| Closed | -$227K | – | 305 |
|
|
2021
Q4 | $227K | Buy |
+3,132
| New | +$227K | 0.01% | 235 |
|